US5137804A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Assay device and immunoassay
Assignee: Revvity Health Sciences Inc
•
Filing: 1988-05-10
•
Granted: 1992-08-11
•
Expires: 2008-05-10
Abstract
Abstract This invention relates to an improved assay device and assay for detecting or quantitating the presence or absence of a substance in a sample. The device has multiple layers comprising a permeable layer (a) having a capture reagent attached to less than the entire membrane, a selectively permeable layer (b) which does not allow assay reagents to pass through (b) and an absorbent layer (c). Layer (b) is in communication with layers (a) and (c). Layer (b) has at least one hole extending therethrough and the hole or holes are directly below the capture reagent in layer (a). The area of the hole or the combined area of the holes is less than the area covered by the capture reagent. This invention also relates to a method of reducing background color development in an absorbent layer of an assay device.
Inventors
- 👤 Richard A. Greene
- 👤 Patricia A. Kasila
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 09:13
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/54366; G01N33/58; G01N33/581; Y; Y10; Y10S; Y10S435/00; Y10S435/962; Y10S435/969; Y10S435/97; Y10S436/00; Y10S436/807; Y10S436/81; Y10S436/825
Claims Analysis
Total Claims: 27
Claim 1
Independent Claim
139 words
In a membrane-based assay device for detecting or quantitating the presence or absence of a substance in a sample suspected to contain said substance, said device having multiple layers comprising: (a) a permeable membrane having attached thereto a capture reagent which specifically binds to said substance. (b) an intermediate layer, and (c) an absorbent layer, wherein layer (b) is in direct communication with layers (a) and (c), the improvement wherein layer (b) is a substantially water impermeable membrane, the membrane having at least one hold therethrough, the hole or holes are directly below the capture reagent and the area of the hole or the combined areas of the holes is less than the area covered by the capture reagent and the improvement further wherein the absorbent layer is saturated with an enzyme inhibitor-containing solution to reduce background color development.
Claim 2
Dependent Claim
139 words
In a membrane-based assay device for detecting or quantitating the presence or absence of a substance in a sample suspected to contain said substance, said device having multiple layers comprising: (a) a permeable membrane having attached thereto a capture reagent which specifically binds to said substance. (b) an intermediate layer, and (c) an absorbent layer, wherein layer (b) is in direct communication with layers (a) and (c), the improvement wherein layer (b) is a substantially water impermeable membrane, the membrane having at least one hold therethrough, the hole or holes are directly below the capture reagent and the area of the hole or the combined areas of the holes is less than the area covered by the capture reagent and the improvement further wherein the absorbent layer is saturated with an enzyme inhibitor-containing solution to reduce background color development.
Claim 3
Dependent Claim
17 words
The device according to claim 1 wherein layer (b) has from about one to about seven holes.
Claim 4
Dependent Claim
13 words
The device according to claim 1 wherein the capture reagent is attached covalently.
Claim 5
Dependent Claim
19 words
The device according to claim 2 wherein said hole or holes are about 25 micrometers by about 1000 micrometers.
Claim 6
Dependent Claim
23 words
The device according to claim 2 wherein said hole or holes occupy 0.4% to about 10% of the area under the capture reagent.
Claim 7
Dependent Claim
20 words
The device according to claim 1 wherein the capture reagent is a monoclonal antibody or an immunoreactive monoclonal antibody fragment.
Claim 8
Dependent Claim
31 words
The device according to claim 1 wherein layer (a) is selected from the group consisting of microporous affinity membranes, membranes with a chemically preactivated surface, and chemically activated hydrophilic microporous membranes.
Claim 9
Dependent Claim
14 words
The device according to claim 1 wherein layer (b) is a fibrous-pourous polytetrafluoroethylene membrane.
Claim 10
Dependent Claim
18 words
The device according to claim 1 wherein the capture reagent is a member of an immune binding pair.
Claim 11
Dependent Claim
17 words
The device according to claim 1 wherein the absorbent layer is saturated with a zinc chloride solution.
Claim 12
Dependent Claim
169 words
A membrane-based immunoassay for detecting or quantitating the presence or absence of a substance in a sample suspected to contain said substance which is performed in a membrane-based immunoassay device having multiple layers comprising: (a) a permeable membrane having a capture reagent attached thereto, (b) an intermediate layer, and (c) an absorbent layer, wherein layer (b) is in direct communication with layer (a) and (c), wherein the sample, detector reagent and other reagents used in the immunoassay are added to the layer (a) and the substance bound to capture reagent on layer (a) is detected or quantitated; the improvement wherein layer (b) is a substantially water impermeable membrane, the membrane having at least one hole therethrough, the hole or holes are directly below the capture reagent and the area of the hole or the combined areas of the holes is less than the area covered by the capture reagent and the improvement further wherein the absorbent layer is saturated with an enzyme inhibitor-containing solution to reduce background color development.
Claim 13
Dependent Claim
169 words
A membrane-based immunoassay for detecting or quantitating the presence or absence of a substance in a sample suspected to contain said substance which is performed in a membrane-based immunoassay device having multiple layers comprising: (a) a permeable membrane having a capture reagent attached thereto, (b) an intermediate layer, and (c) an absorbent layer, wherein layer (b) is in direct communication with layer (a) and (c), wherein the sample, detector reagent and other reagents used in the immunoassay are added to the layer (a) and the substance bound to capture reagent on layer (a) is detected or quantitated; the improvement wherein layer (b) is a substantially water impermeable membrane, the membrane having at least one hole therethrough, the hole or holes are directly below the capture reagent and the area of the hole or the combined areas of the holes is less than the area covered by the capture reagent and the improvement further wherein the absorbent layer is saturated with an enzyme inhibitor-containing solution to reduce background color development.
Claim 14
Dependent Claim
33 words
The immunoassay according to claim 11 wherein the substance to be detected or quantitated is selected from the group consisting of polypeptides, proteins, polysaccharides, nuclei acids, blood clotting factors, hormones, bacteria and viruses.
Claim 15
Dependent Claim
51 words
The immunoassay according to claim 12 wherein the substance to be detected is a virus selected from the group consisting of adenoviruses, herpes simplex, varicella zoster, herpes virus B, cytomegalovirus, Epstein-Barr virus, pox virus, picornaviruses, orthomyxoviruses, paramyxoviruses, coronaviruses, rhabdoviruses, togaviruses, bunyaviruses, arenaviruses, rubella virus, arboviruses, reoviruses, hepatitis, retroviruses and oncogenic viruses.
Claim 16
Dependent Claim
38 words
The immunoassay according to claim 13 wherein the sample is transferred directly into a viral transport tube containing a buffered detergent solution comprising buffer, detergent and a carrier protein which minimizes nonimmunologic binding of proteins in the sample.
Claim 17
Dependent Claim
20 words
The immunoassay according to claim 11 wherein the capture reagent is a monoclonal antibody or an immunoreactive monoclonal antibody fragment.
Claim 18
Dependent Claim
18 words
The immunoassay according to claim 11 wherein the capture reagent is a member of an immune binding pair.
Claim 19
Dependent Claim
20 words
The immunoassay according to claim 11 wherein the detector reagent is selected from a member of an immune binding pair.
Claim 20
Dependent Claim
19 words
The immunoassay according to claim 11 wherein the detect reagent is a monoclonal antibody or immunoreactive monoclonal antibody fragment.
Claim 21
Dependent Claim
38 words
The immunoassay according to claim 18 wherein the antibody or fragment may be labeled or unlabeled and when the antibody or fragment is unlabeled then it is reacted with a labeled antibody to the unlabeled antibody or fragment.
Claim 22
Dependent Claim
35 words
The immunoassay according to claim 18 wherein the antibody or fragment is labeled with a component of a reporter system or is labeled with a first member of a specific immune or non-immune binding pair.
Claim 23
Dependent Claim
32 words
The immunoassay according to claim 20 wherein the monoclonal antibody or fragment is labeled with a reporter selected from the group consisting of radioactive isotopes, enzymes, fluorogenic, magnetic, chemiluminescent and electrochemical materials.
Claim 24
Dependent Claim
42 words
The immunoassay according to claim 20 wherein the antibody or fragment is reacted with the second member of the binding pair to which is attached a reporter selected from the group consisting of radioactive isotopes, enzymes, fluorogenic, magnetic, chemiluminescent and electrochemical materials.
Claim 25
Dependent Claim
15 words
The immunoassay according to claim 18 wherein the antibody or fragment is labeled with biotin.
Claim 26
Dependent Claim
17 words
The immunoassay according to claim 23 wherein the biotinylated antibody or fragment is reacted with streptavidin-alkaline phosphatase.
Claim 27
Dependent Claim
27 words
The immunoassay according to claim 24 wherein the product of claim 21 is reacted with 5-bromo-4-chloro-indoxyl phosphate (BCIP) and 2,2'-di-(p-nitrophenyl) -5,5'-diphenyl-3,3'-(3,3'-dimethoxy-4,4'-diphenylene) -ditetrazolium chloride (NBT) as enzyme substrate.
References Cited (Backward Citations)
US31006A
Cited
US3232710A
Cited
US2785057A
Cited
US3011874A
Cited
US3620677A
Cited
US3249513A
Cited
US3341427A
Cited
US3482943A
Cited
US3420205A
Cited
US3511608A
Cited
US3715192A
Cited
US3663374A
Cited
GB1348938A
Cited
US3783105A
Cited
US3791933A
Cited
US3802842A
Cited
GB1401298A
Cited
GB1401297A
Cited
US3723064A
Cited
US3888629A
Cited
US3896217A
Cited
US4092115A
Cited
US3901657A
Cited
US4201763A
Cited
US4087248A
Cited
US4098876A
Cited
US4407943A
Cited
US4200690A
Cited
GB1564578A
Cited
GB2001172A
Cited
GB2008767A
Cited
GB2018986A
Cited
US4244940A
Cited
US4277560A
Cited
US4246339A
Cited
US4258001A
Cited
US4235601A
Cited
US4361537A
Cited
US4391904A
Cited
US4366241A
Cited
US4366241B1
Cited
US4472498A
Cited
US4652533A
Cited
US4581331A
Cited
US4549655A
Cited
US4849505A
Cited
US4632901A
Cited
EP0200381A1
Cited
US4632461A
Cited
US4748115A
Cited
EP0239222A1
Cited
US4828980A
Cited
US5006464A
Cited
US4818677A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-08-11 | 1996-02-10 | 1996-08-11 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-08-11 | 2000-02-10 | 2000-08-11 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-08-11 | 2004-02-10 | 2004-08-11 | $7700.00 | Window Closed / Lapsed |